|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| CRPS | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Complex Regional Pain Syndromes | |||||
| 3 | More general conditions related to this trial | ||||
| Autonomic Nervous System Diseases | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Peripheral Nervous System Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| pregabalin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Anticonvulsants | |||||
| Central Nervous System Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Rush University Medical Center | |||||
| Pfizer | |||||